BioSpace News Archive

Earle Chambers, Ph.D., M.P.H., has been appointed director of the division of research in the department of family and social medicine at Albert Einstein College of Medicine and Montefiore Health System

Ridgeback Biotherapeutics LP (“Ridgeback”), a biotechnology company experienced in antiviral drug development, today announced the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted priority review designation for Ridgeback’s investigational Ebola treatment, ansuvimab (mAb114). The FDA granted Breakthrough Therapy Designation status to ansuvimab as a treatment for Ebola in Se

Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its second quarter 2020 financial results after the close of market on Wednesday, August 5, 2020. Tricida will host a conference call and webcast at 4:30 pm Eastern Time to discuss its financial results and business progress.

Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that the required number of survival events for the pivotal Phase 3 INSPIRE has been reached.

Agenus Inc. (NASDAQ: AGEN), today announced it will provide an update on programs and plans and release its second quarter 2020 financial results before the market opens on Thursday, August 6, 2020.

Wisconsin Pharmacal Company, the official licensee of the Coleman brand of personal insect repellents, recently introduced its new Coleman Tick Protection Insect Repellent . The new EPA-registered personal insect repellent includes CDC-recommended 25% DEET to repel ticks that may carry Lyme disease, repelling ticks with an unscented

32 Kaiser Permanente hospitals identified as ‘high performing’ for multiple specialties, procedures, and common conditions. [29-July-2020] OAKLAND, Calif. , July 29, 2020 /PRNewswire/ -- Kaiser Permanente hospitals are among the best in the nation for delivering high-quality care, according to the U.S. News & World Report’s 2020-21 Best Hospitals rankings.

A recent feasibility study conducted in collaboration between LEO Innovation Lab, VisualDx, and the German Association of Dermatological Prevention found, for the first time, a 34% increase in diagnostic accuracy by general practitioners (GPs) who use technology to assist in patient diagnosis in skin conditions, while at the same time improving patient satisfaction.

The National Disease Research Interchange (NDRI), a world leader in the procurement and distribution of biospecimens to advance research, recognized Donor Network West, an Organ Procurement Organization (OPO) which serves northern California and northern Nevada, as the recipient of the second annual NDRI/AOPO Empowering Research and Discovery Award for outstanding commitment to the advancement of research.

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced the company will be participating in the upcoming Canaccord Genuity 40th Annual Virtual Growth Conference.